A new vaccine against advanced cutaneous melanoma will be available to UK patients through an NHS program
Sanziana Georgescu
Health
sursa foto: pexels.com
Always see our news on Google
<p>The UK's National Health Service is launching an innovative vaccine, iSCICIB1+, for patients with advanced cutaneous melanoma to improve the immune system's response to immunotherapy treatments. The program, part of the Cancer Vaccine Launch Pad, will enable rapid access to clinical trials, targeting 10,000 patients by 2030. The first patients are expected to start treatment next month, and the initiative highlights the potential of vaccines to transform cancer care and save lives. Melanoma is the fifth most common cancer in the UK and early monitoring is essential for effective treatment.
Sources
Latest News
15:39
Lithuanian officials suspect that Russia plans to use drones captured from Ukrainians for provocations in the Baltic region
15:34
The GDP of the European Union was estimated at 18.8 trillion euros in 2025, while Romania's economy was estimated at 380 billion euros, representing 2% of the total GDP.
15:27
A national operational center in the energy sector will be created to manage the energy crisis / Ilie Bolojan: "Citizens will not be limited or disconnected"
15:25
The government approved three memorandums for the filling of 402 vacant positions in Transgaz, Transelectrica, and Hidroelectrica, necessary for the security of the national energy system.
15:14
Users who purchase road tax online may incur significant additional fees. CNAIR recommends purchasing only from the official portal.
See more news
NEWS ON THE SAME TOPICS
.webp)
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
.webp)
